会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • FUSED QUINOLINE DERIVATIVE AND USE THEREOF
    • 熔融喹啉衍生物及其用途
    • US20090270625A1
    • 2009-10-29
    • US12476619
    • 2009-06-02
    • Masahiro KajinoNicholas William HirdNaoki TaruiHiroshi BannoYasuhiko KawanoNobuhiro Inatomi
    • Masahiro KajinoNicholas William HirdNaoki TaruiHiroshi BannoYasuhiko KawanoNobuhiro Inatomi
    • C07D471/04
    • C07D471/04
    • The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I) wherein R1 is a hydrogen atom and the like; R2 is a hydrogen atom, a hydrocarbon group optionally having substituent(s) and the like; R3 is unsubstituted (i.e., absence), a hydrogen atom and the like; R4 and R5 are the same or different and each is a hydrogen atom, a hydrocarbon group optionally having substituent(s), and the like; R6 is (cyclic group optionally having substituent(s))-carbonyl, and the like; R7, R8, R9 and R10 are the same or different and each is a hydrogen atom, halogen and the like; or R7 and R8, R8 and R9, and R9 and R10 may form a ring together with the adjacent carbon atoms; n is an integer of 1 to 5; — --- represents unsubstituted (i.e., absence) or a single bond; and represents a single bond or a double bond, or a salt thereof, and the like.
    • 本发明旨在提供具有神经激肽2(NK2)受体拮抗作用的喹啉衍生物,其涉及式(I)表示的化合物,其中R1为氢原子等; R2是氢原子,任选具有取代基的烃基等; R3是未取代的(即不存在),氢原子等; R 4和R 5相同或不同,各自为氢原子,任选具有取代基的烃基等; R6是(任选具有取代基的环状基团) - 羰基等; R 7,R 8,R 9和R 10相同或不同,各自为氢原子,卤素等; 或R 7和R 8,R 8和R 9,并且R 9和R 10可与相邻碳原子一起形成环; n为1〜5的整数, ---表示未取代(即不存在)或单键; < img id =“CUSTOM-CHARACTER-00001”he =“2.79mm”wi =“7.03mm”file =“US20090270625A1-20091029-P00001.TIF”img-content =“character”img-format =“tif”/ >表示单键或双键,或其盐等。
    • 2. 发明申请
    • FUSED QUINOLINE DERIVATIVE AND USE THEREOF
    • 熔融喹啉衍生物及其用途
    • US20090258893A1
    • 2009-10-15
    • US12476626
    • 2009-06-02
    • Masahiro KajinoNicholas William HirdNaoki TaruiHiroshi BannoYasuhiko KawanoNobuhiro Inatomi
    • Masahiro KajinoNicholas William HirdNaoki TaruiHiroshi BannoYasuhiko KawanoNobuhiro Inatomi
    • A61K31/437C07D471/04A61P1/00
    • C07D471/04
    • The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I) wherein R1 is a hydrogen atom and the like; R2 is a hydrogen atom, a hydrocarbon group optionally having substituent(s) and the like; R3 is unsubstituted (i.e., absence), a hydrogen atom and the like; R4 and R5 are the same or different and each is a hydrogen atom, a hydrocarbon group optionally having substituent(s), and the like; R6 is (cyclic group optionally having substituent(s))-carbonyl, and the like; R7, R8, R9 and R10 are the same or different and each is a hydrogen atom, halogen and the like; or R7 and R8, R8 and R9, and R9 and R10 may form a ring together with the adjacent carbon atoms; n is an integer of 1 to 5; represents unsubstituted (i.e., absence) or a single bond; and represents a single bond or a double bond, or a salt thereof, and the like.
    • 本发明旨在提供具有神经激肽2(NK2)受体拮抗作用的喹啉衍生物,其涉及式(I)表示的化合物,其中R1为氢原子等; R2是氢原子,任选具有取代基的烃基等; R3是未取代的(即不存在),氢原子等; R 4和R 5相同或不同,各自为氢原子,任选具有取代基的烃基等; R6是(任选具有取代基的环状基团) - 羰基等; R 7,R 8,R 9和R 10相同或不同,各自为氢原子,卤素等; 或R 7和R 8,R 8和R 9,并且R 9和R 10可与相邻碳原子一起形成环; n为1〜5的整数, “img id =”CUSTOM-CHARACTER-00001“he =”0.68mm“wi =”3.13mm“file =”US20090258893A1-20091015-P00001.TIF“img-content =”character“img-format =”tif“/> 表示未取代的(即不存在)或单键; < img id =“CUSTOM-CHARACTER-00002”he =“1.02mm”wi =“3.13mm”file =“US20090258893A1-20091015-P00002.TIF”img-content =“character”img-format =“tif”/ >表示单键或双键,或其盐等。